Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F L Lanza

Showing results (61-70 of 67) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 67 results.
Gastroenterology|August 1, 1983
Natural history of benign esophageal stricture treated by dilatationD J Patterson, D Y Graham, J L Smith, et al.
The American Journal of Gastroenterology|July 1, 1992
A multicenter, double-blind, randomized, placebo-controlled comparison of nocturnal roxatidine in the treatment of active duodenal ulcer disease. Multicenter Roxatidine Cooperative Study GroupN H Gilinsky, P Bright-Asare, B L Cobert, et al.
The American Journal of Medicine|March 24, 1986
Effects of flurbiprofen and aspirin on the gastric and duodenal mucosa. An endoscopic comparisonF L Lanza, G L Royer, R S Nelson, et al.
Alimentary Pharmacology & Therapeutics|June 26, 1999
Specific inhibition of cyclooxygenase-2 with MK-0966 is associated with less gastroduodenal damage than either aspirin or ibuprofenF L Lanza, M F Rack, T J Simon, et al.
Arthritis and Rheumatism|September 29, 1998
Preliminary study of the safety and efficacy of SC-58635, a novel cyclooxygenase 2 inhibitor: efficacy and safety in two placebo-controlled trials in osteoarthritis and rheumatoid arthritis, and studies of gastrointestinal and platelet effectsL S Simon, F L Lanza, P E Lipsky, et al.
Gastroenterology|October 1, 1989
Suppression of nocturnal acid secretion with famotidine accelerates gastric ulcer healingA J McCullough, D Y Graham, T E Knuff, et al.
Texas Medicine|September 1, 1987
Colorectal cancer. Colorectal Oncology Workgroup, Legislative Task Force on Cancer in TexasW H Schwesinger, H R Bailey, P C Canizaro, et al.
Pageof 7

Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
Gastroenterology|August 1, 1983
Natural history of benign esophageal stricture treated by dilatationD J Patterson, D Y Graham, J L Smith, et al.
The American Journal of Gastroenterology|July 1, 1992
A multicenter, double-blind, randomized, placebo-controlled comparison of nocturnal roxatidine in the treatment of active duodenal ulcer disease. Multicenter Roxatidine Cooperative Study GroupN H Gilinsky, P Bright-Asare, B L Cobert, et al.
The American Journal of Medicine|March 24, 1986
Effects of flurbiprofen and aspirin on the gastric and duodenal mucosa. An endoscopic comparisonF L Lanza, G L Royer, R S Nelson, et al.
Alimentary Pharmacology & Therapeutics|June 26, 1999
Specific inhibition of cyclooxygenase-2 with MK-0966 is associated with less gastroduodenal damage than either aspirin or ibuprofenF L Lanza, M F Rack, T J Simon, et al.
Arthritis and Rheumatism|September 29, 1998
Preliminary study of the safety and efficacy of SC-58635, a novel cyclooxygenase 2 inhibitor: efficacy and safety in two placebo-controlled trials in osteoarthritis and rheumatoid arthritis, and studies of gastrointestinal and platelet effectsL S Simon, F L Lanza, P E Lipsky, et al.
Gastroenterology|October 1, 1989
Suppression of nocturnal acid secretion with famotidine accelerates gastric ulcer healingA J McCullough, D Y Graham, T E Knuff, et al.
Texas Medicine|September 1, 1987
Colorectal cancer. Colorectal Oncology Workgroup, Legislative Task Force on Cancer in TexasW H Schwesinger, H R Bailey, P C Canizaro, et al.
Pageof 7